No Data
No Data
Express News | SeaStar Medical Holding Corp - on Dec 24, Notified by Nasdaq of Non-Compliance
Express News | SeaStar Medical Estimates US Total Addressable Market For Its Proprietary, Patented Selective Cytopheretic Device In Five Clinical Indications Of $25B - $33B
SeaStar Medical Projects Multibillion-Dollar Market Potential for Its Selective Cytopheretic Device in Initial Target Indications
SeaStar Medical To Discuss Business Progress And Updates Tomorrow
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
SeaStar Medical Announces Activation of Sentara Norfolk General as Active Site
No Data
WolfMat : baaad very bad
Trytosaveabit OP WolfMat : Could be yup! Unless we can get a massive unregistered private placement! Hehehe
WolfMat Trytosaveabit OP : It's really the russian roulette